Press release
Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Market Across 7 Key Regions Projected to Hit USD 14.50 Billion by 2035, Report by IMARC Group
ABSSSI Market Across 7 Key Regions Projected to Hit USD 14.50 Billion by 2035, Report by IMARC Group
Due to increasing patients and growing antibiotic resistance and advances in diagnostics and treatment technologies, the acute bacterial skin and skin structure infections in 2025 find exceptional growth. ABSSSI encompasses a broad spectrum of serious infections like cellulitis, wound infections, and major abscesses caused by an organism like Staphylococcus aureus and Streptococcus species. These types of infections mostly require an immediate diagnosis and a course of antibiotic treatment.
Request a PDF Sample Report: https://www.imarcgroup.com/acute-bacterial-skin-skin-structure-infections-market/requestsample
On increasing cases worldwide, skin infections are one of the main areas responsible for the growth of this market in 2025. Various contributory factors include diabetes, obesity, surgeries, etc. There is an increasing population of the elderly, who are prone to complications caused by infections. Urban lifestyle is hygienically conducive in some parts and is also responsible for causing bacterial skin infection.
One prominent trend in the ABSSSI market is growing anxiety over antibiotic resistance. Increasing antibiotic resistance among infections caused by methicillin-resistant Staphylococcus aureus (MRSA) is occurring against common antibacterials. Pharmaceutical companies, thus, focus on developing novel antibiotics with improved activity against resistant organisms. In 2025, entering the market is some newly launched drugs that further take the stage for its improved safety profile and efficacy profile with other enhancements.
Buy Now Full Report: https://www.imarcgroup.com/checkout?id=10589&method=809
Acute Bacterial Skin and Skin Structure Infections Market Epidemiology
1. Public Health Initiatives Driving Market Support
Hygiene Education and Infection Prevention:
Efforts are encouraging correct hygiene practices to minimize the risk of infection.
Responsible Antibiotic Use:
Initiatives to control antibiotic resistance through promotion and prescription guidelines.
Improved Access to Early Treatment:
Governments and healthcare systems are striving to provide more care in secluded and less-equipped regions.
2. Innovation and Patient-Centric Care
New Antibiotics:
Research into new drugs addressing the resistant bacterial strains.
Advanced Diagnostics:
Drugs facilitating quicker and more precise infection identification.
Enhanced Treatment Approaches:
Focus on quicker recovery, fewer complications, and more secure care practices.
3. A Positive Future for the ABSSSI Market
The 2025 ABSSSI market is driven by innovation, accessibility, and international collaboration.
Healthcare professionals and scientists play a key role in sustaining advancement in the treatment of acute bacterial skin infections.
Other reports by IMARC Group:
Von Willebrand Disease Market https://www.imarcgroup.com/von-willebrand-disease-market
Pertussis market https://www.imarcgroup.com/pertussis-market
Muscle Spasticity Market https://www.imarcgroup.com/muscle-spasticity-market
Androgenetic Alopecia Market https://www.imarcgroup.com/androgenetic-alopecia-market
Ankylosing Spondylitis Market https://www.imarcgroup.com/ankylosing-spondylitis-market
Advanced Liver Cancer Market https://www.imarcgroup.com/advanced-liver-cancer-market
Contact US:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145
About Us:
IMARC Group is a global management consulting firm that helps the world's most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services.
IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Market Across 7 Key Regions Projected to Hit USD 14.50 Billion by 2035, Report by IMARC Group here
News-ID: 4001892 • Views: …
More Releases from IMARC Group
Brazil Steel Market Forecast: Revenue, Production & Demand Outlook Through 2034
Brazil's steel industry sits at the intersection of two powerful forces: a construction and infrastructure boom that shows no signs of slowing, and a global decarbonization push that is reshaping how steel itself gets made. The Brazil steel market, valued at USD 17.3 Billion in 2025, is projected to reach USD 24.9 Billion by 2034, growing at a compound annual rate of 4.18% between 2026 and 2034. That trajectory reflects…
Europe Electric Car Market Report 2026: Revenue, CAGR & Emerging Opportunities B …
Europe's electric car industry is entering a phase where policy, affordability, and infrastructure are finally moving in the same direction at the same time. The Europe electric car market, valued at USD 47.1 Billion in 2025, is projected to reach USD 109.0 Billion by 2034, growing at a compound annual rate of 9.9% between 2026 and 2034. This trajectory reflects more than doubling market value within a decade, driven by…
Mexico Precision Agriculture Market Size Projected to Reach USD 289.5 Million by …
IMARC Group has recently released a new research study titled "Mexico Precision Agriculture Market Report by Technology (GNSS/GPS Systems, GIS, Remote Sensing, Variable Rate Technology (VRT), Others), Type (Automation and Control Systems, Sensing and Monitoring Devices, Farm Management System), Component (Hardware, Software), Application (Mapping, Crop Scouting, Yield Monitoring, Soil Monitoring, Precision Irrigation, Others), and Region 2026-2034," offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends and competitive…
Brazil Third-Party Logistics Market to Reach USD 59.04 Billion by 2034 at 7.26% …
Brazil's outsourced logistics sector is scaling rapidly as e-commerce fulfillment, manufacturing recovery, and government-backed infrastructure investment converge into a single growth narrative. The Brazil third-party logistics market, valued at USD 31.42 Billion in 2025, is projected to reach USD 59.04 Billion by 2034, growing at a compound annual rate of 7.26% between 2026 and 2034, a pace that positions Brazil among Latin America's fastest-expanding logistics economies.
Download a sample copy of…
More Releases for ABSSSI
ABSSSI Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Lands …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Acute Bacterial Skin and Skin-Structure Infection pipeline constitutes 2+ key companies continuously working towards developing 2+ Acute Bacterial Skin and Skin-Structure Infection treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"Acute Bacterial Skin and Skin-Structure Infection Pipeline Insight, 2025" report by DelveInsight outlines comprehensive insights into the present clinical…
Revolutionizing Care: Breakthroughs Propel the ABSSSI Treatment Market into a Ne …
Acute Bacterial Skin and Skin Structure Infections (ABSSSI) represent a significant clinical and economic burden worldwide, affecting patients across outpatient clinics, hospitals, and long-term care facilities. From simple cellulitis to complex wound infections, these conditions require prompt, effective therapy to prevent serious complications and reduce healthcare costs. Today, the ABSSSI treatment market is undergoing a renaissance, driven by novel antibiotic classes, innovative delivery systems, and a heightened focus on antimicrobial…
ABSSSI Therapeutics Market Size in the 7MM is anticipated to increase by 2034 an …
DelveInsight's "Acute Bacterial Skin and Skin Structure Infections Market Insights, Epidemiology and Market Forecast - 2034" report delivers an in-depth understanding of the Acute Bacterial Skin and Skin Structure Infections, historical and forecasted epidemiology as well as the Acute Bacterial Skin and Skin Structure Infections market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United Kingdom, and Japan.
Unlock key insights into the ABSSSI Market! Download…
Acute Bacterial Skin and Skin-Structure Infection (ABSSSI) Treatment Market Size …
Acute Bacterial Skin and Skin Structure Infections Treatment Market is projected to witness substantial growth over the next few years, driven by advancements in treatment modalities and increasing awareness of the condition. The pipeline for Acute Bacterial Skin and Skin Structure Infections Therapeutics includes promising candidates that aim to not only treat acute attacks but also prevent recurrence.
DelveInsight's "Acute Bacterial Skin and Skin Structure Infections Market Insights, Epidemiology and…
Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Market – Detailed …
Acute Bacterial Skin and Skin Structure Infections Market Report 2021 added recently by Coherent Market Insights, evaluates the industry in terms of market size, market share, revenue estimation, and geographical outlook. The study also delivers a precise summary that illustrates the competitive milieu, growth opportunities and application landscape of the Acute Bacterial Skin and Skin Structure Infections depending on the industry's financial and non-financial impact. The complete range of information…
Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Market Rapidly Devel …
The major market driver for growth of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) market is increasing research and development activities by pharmaceutical and biopharmaceutical companies to develop new products and novel treatment. For instance, in 2017, Cempra announced promising data from the phase 3 trial of Fusidic acid for the treatment of ABSSSI. In same year, Melinta Therapeutics received US FDA for its product Baxdela, a delafloxacin based…
